{Abacavir Sulfate (CAS 188062-50-2): A Comprehensive Examination of said Compound
Abacavir sulfate, identified by CAS registry number 188062-50-2, represents a crucial antiviral utilized primarily in the treatment of human immunodeficiency virus infection, often as part of a combination regimen . This functions as a nucleoside reverse polymerase inhibitor, preventing the virus's ability to replicate . Patients abacavir must undergo genetic evaluation for the HLA-B*57:01 allele due to the risk of a severe hypersensitivity reaction if administered to those who are affected. The formulation is typically given orally, and its effectiveness relies upon consistent compliance to the recommended dosage.
```
Abarelix: Thorough Analysis of the Molecule with Registry Designation 183552-38-7
Abarelix, identified by its Identification Designation 183552-38-7, represents a novel peptide designed primarily for the therapy of benign prostatic hyperplasia (BPH). This sophisticated medication functions as a targeted gonadotropin-releasing hormone (GnRH) inhibitor, disrupting the usual hormonal cycle that regulates testosterone synthesis . Consequently, abarelix causes a rapid reduction in testosterone levels , successfully alleviating the symptoms associated with BPH. Studies have focused on its potential application in other hormone-sensitive ailments, though its use remains largely limited to BPH care.
```text
Abiraterone Acetate (CAS 154229-18-2): Properties and Applications
Abiraterone acetate, identified by the Chemical Abstracts Service registry number 154229-18-2, represents a significant therapeutic agent in oncology, particularly for metastatic prostate cancer. The chemical structure is that of a prodrug, demonstrating it requires metabolic conversion within the body to the active form, abiraterone. Regarding its properties, abiraterone acetate exists as a white to off-white powder, possessing limited solubility in water but increased solubility in organic solvents like ethanol or dimethyl sulfoxide. Its molecular formula is C26H30O3, and its molecular weight is approximately 402.51 g/mol. Mainly, abiraterone acetate functions as an inhibitor of CYP17A1, an enzyme crucial for androgen biosynthesis. This action reduces the production of testosterone in the testes, adrenal glands, and prostate cancer tissues themselves, thereby disrupting cancer cell growth.
```
CAS Spotlight: Examining Abacavir ’s Molecular Nature
Determining the accurate molecular identity of (Abacavir) is essential for guaranteeing therapeutic efficacy and patient security. Researchers at CAS have conducted a detailed study utilizing sophisticated instrumental approaches to verify the molecule's unique signature. This assessment incorporates examining important characteristics such as infrared patterns , mass analysis , and proton resonance imaging , leading in a full report of this key therapeutic get more info compound .
Understanding Abarelix: The Analysis of the CAS Registry Number and Relevance
Understanding the details regarding pharmaceutical medication discovery sometimes requires deciphering distinct references. Abarelix, an GnRH blocker utilized in treating prostate cancer , is no exception . Its CAS number, precisely 135838-34-4, serves the critical link within the universal database of synthetic substances . This identification permits scientists to clinicians to accurately identify data related about its characteristics , security, & efficacy .
Abiraterone Acetate: Chemical Profile and Identification via CAS 154229-18-2
Abiraterone acetate, a crucial medicinal compound used in the management of prostate tumors, presents a distinct chemical identity. Its identification is frequently confirmed through the Chemical Abstracts Service (CAS) registry number 154229-18-2, a unique code for this specific entity. Chemically, it’s an acetate salt of abiraterone, possessing a molecular composition of C26H30O3 and a molecular mass of approximately 402.51 g/mol. The CAS number serves as a reliable approach for ensuring the correct substance is being utilized in research and patient settings, preventing errors and confirming accurate results. Additional analysis, employing techniques like weight spectrometry and nuclear magnetic resonance, supports this identification and clarifies its quality.